Literature DB >> 16465687

Renewed promise. Annual AIDS vaccine meeting highlights recent data from clinical trials and lessons on recruitment and retention of volunteers.

Kristen Jill Kresge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16465687

Source DB:  PubMed          Journal:  IAVI Rep        ISSN： 1816-6253


× No keyword cloud information.
  4 in total

1.  Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine.

Authors:  Kathleen M Daddario-DiCaprio; Thomas W Geisbert; Joan B Geisbert; Ute Ströher; Lisa E Hensley; Allen Grolla; Elizabeth A Fritz; Friederike Feldmann; Heinz Feldmann; Steven M Jones
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses.

Authors:  Marcio O Lasaro; Nia Tatsis; Scott E Hensley; J Charles Whitbeck; Shih-Wen Lin; John J Rux; E John Wherry; Gary H Cohen; Roselyn J Eisenberg; Hildegund C Ertl
Journal:  Nat Med       Date:  2008-01-13       Impact factor: 53.440

3.  Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors.

Authors:  Kimberly McCoy; Nia Tatsis; Birgit Korioth-Schmitz; Marcio O Lasaro; Scott E Hensley; Shih-Wen Lin; Yan Li; Wynetta Giles-Davis; Ann Cun; Dongming Zhou; Zhiquan Xiang; Norman L Letvin; Hildegund C J Ertl
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

4.  A novel chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines.

Authors:  Daniela Peruzzi; Sridhar Dharmapuri; Agostino Cirillo; Bruno Ercole Bruni; Alfredo Nicosia; Riccardo Cortese; Stefano Colloca; Gennaro Ciliberto; Nicola La Monica; Luigi Aurisicchio
Journal:  Vaccine       Date:  2009-01-20       Impact factor: 3.641
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.